By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Naurex Inc. 

1801 Maple Avenue
Suite 4300
Evanston  Illinois  60201  U.S.A.
Phone: 317-250-3276 Fax: n/a



Start Up

Company News
Naurex Inc. To Present At 22nd Annual BioCentury Future Leaders In The Biotech Industry Conference 3/16/2015 9:30:58 AM
Naurex Inc.'s First Orally Active Molecule, NRX-1074, Demonstrates Statistically Significant Improvement In Depression Scores Within 24 Hours In Phase 2 Study For Major Depressive Disorder 1/27/2015 7:28:28 AM
Naurex Inc. To Present At 33rd Annual J.P. Morgan Healthcare Conference 12/19/2014 9:46:09 AM
Naurex Inc.'s GLYX-13 Demonstrates Robust, Sustained Antidepressant Effects And Excellent Tolerability In Phase 2b Study 12/10/2014 7:41:02 AM
Biopharma Startup Naurex Inc. Scores $80 Million Series C Financing 12/3/2014 6:53:34 AM
Naurex Inc. Release: Data Presented At Society For Neuroscience Demonstrates That Naurex's GLYX-13 Enhances Synaptic Plasticity Through NMDA Receptor Modulation 11/17/2014 2:57:09 PM
Naurex Inc. To Present At UBS Global Healthcare Conference 5/15/2014 7:36:45 AM
Naurex Inc.'s Two Lead Antidepressant Candidates Achieve Major Milestones In Phase 2 Trials, Raises $25 Million 5/6/2014 6:30:44 AM
FDA Grants Fast Track Designation To Naurex Inc.'s Rapid-Acting Novel Antidepressant GLYX-13 3/3/2014 10:09:09 AM
Naurex Inc. To Present At Cowen and Company 34th Annual Health Care Conference 2/27/2014 6:43:43 AM